For the quarter ending 2026-03-31, DWTX has $95,207,871 in assets. $14,584,519 in debts. $13,227,839 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 13,227,839 | 6,524,744 | 10,126,710 | 13,402,809 |
| Prepaid expenses and other current assets | 1,776,299 | 1,906,462 | 1,528,667 | 1,301,485 |
| Total current assets | 15,004,138 | 8,431,206 | 11,655,377 | 14,704,294 |
| Property and equipment, net | 12,541 | 12,754 | 15,293 | 16,179 |
| Right-of-use assets | 146,754 | 163,140 | 174,008 | 190,964 |
| Prepaid expenses, long-term | 18,719 | 19,037 | 18,743 | 19,125 |
| Goodwill | 12,193,825 | 12,401,118 | 12,209,591 | 12,458,383 |
| Intangible assets | 67,831,894 | 68,985,026 | 67,919,601 | 69,303,582 |
| Deferred issuance costs | - | 158,956 | - | - |
| Total assets | 95,207,871 | 90,171,237 | 91,992,613 | 96,692,527 |
| Accounts payable | 144,400 | 760,945 | 584,602 | 498,118 |
| Accrued expenses | 2,348,737 | 2,241,417 | 1,957,641 | 1,332,574 |
| Deferred sublease income | 9,573 | - | - | - |
| Lease liability, current portion | 57,314 | 56,841 | 54,566 | 54,496 |
| Total current liabilities | 2,560,024 | 3,059,203 | 2,596,809 | 1,885,188 |
| Deferred sublease income, long-term | 28,718 | - | - | - |
| Lease liability, long-term portion | 87,616 | 105,763 | 120,212 | 132,494 |
| Deferred tax liability | 11,908,161 | 12,109,404 | 11,890,483 | 12,134,222 |
| Total liabilities | 14,584,519 | 15,274,370 | 14,607,504 | 14,151,904 |
| Preferred stock-Seriesa Non Voting Convertible Preferred Stock | - | 0 | 5,535,067 | - |
| Preferred stock-Seriesa1Non Voting Convertible Preferred Stock | - | 0 | 24,994,461 | 24,994,461 |
| Preferred stock-Seriesa2Non Voting Convertible Preferred Stock | - | 0 | 9,800,839 | - |
| Preferred stock-Preferred Stock Excluding Seriesa And Seriesa1Non Voting Convertible Preferred Stock | - | - | - | 0 |
| Series a non-voting convertible preferred stock, 0.0001 par value 2,104 shares authorized and 2,103.1494 shares issued and outstanding at september 30, 2025 and 2,270 shares authorized and 2,213.8044 shares issued and outstanding at december 31, 2024 | - | - | 70,126,957 | 75,662,024 |
| Preferred stock-Preferred Stock Excluding Seriesa Seriesa1And Seriesa2Non Voting Convertible Preferred Stock | - | 0 | - | - |
| Common stock, 0.0001 par value 43,000,000 shares authorized 33,409,271 and 33,401,553 shares issued and outstanding at march 31, 2026, respectively and 29,751,234 and 29,743,516 shares issued and outstanding at december 31, 2025, respectively | 3,340 | 2,974 | 229 | 191 |
| Additional paid-in capital | 195,703,020 | 183,856,376 | 73,158,686 | 71,001,615 |
| Accumulated deficit | -113,062,930 | -108,076,316 | -104,295,867 | -88,551,251 |
| Accumulated other comprehensive loss | -1,720,950 | -587,039 | -1,636,135 | -267,289 |
| Stockholders' equity before treasury stock | 80,922,480 | 75,195,995 | 7,557,280 | 7,177,727 |
| Less treasury stock, 7,718 shares of common stock at cost | 299,128 | 299,128 | 299,128 | 299,128 |
| Total stockholders' equity | 80,623,352 | 74,896,867 | 7,258,152 | 6,878,599 |
| Total liabilities, series a non-voting convertible preferred stock and stockholders' equity | 95,207,871 | 90,171,237 | 91,992,613 | 96,692,527 |
Dogwood Therapeutics, Inc. (DWTX)
Dogwood Therapeutics, Inc. (DWTX)